Article Text

Download PDFPDF
Metabolic modulation in heart failure: high time for a definitive clinical trial

Statistics from


  • Linked articles 208751.

  • Funding The authors acknowledge funding by the British Heart Foundation and the NIHR Oxford Biomedical Research Centre.

  • Competing interests HA has in partnership successfully applied for method of use patents for the use of perhexiline in heart failure and cardiomyopathies.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles